Abstract
Provided herein are methods for the activation and expansion of genetically-modified T cells, such as tumor infiltrating lymphocytes. In some cases, cells of the embodiments can be used for the therapeutic treatment of human diseases, such as cancer.
Full Text
What is claimed is:
Provided herein are methods for the activation and expansion of genetically-modified T cells, such as tumor infiltrating lymphocytes. In some cases, cells of the embodiments can be used for the therapeutic treatment of human diseases, such as cancer.
Timeline
Filed
05/15/2026Published
09/03/2026Granted
Not AvailableIPC Codes(7)
C07K 16/28:against receptors, cell surface antigens or cell surface determinants
A61K 40/11:T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
A61K 40/42:Cancer antigens